Loading…

Neurocognitive impairment influences quality of life in HIV-infected patients receiving HAART

The objective of the study was to determine the association of neurocognitive impairment with health-related quality of life (HRQoL) in patients receiving highly active antiretroviral therapy (HAART). Seventy subjects were cross-sectionally analysed with a standardized neuropsychological test batter...

Full description

Saved in:
Bibliographic Details
Published in:International journal of STD & AIDS 2004-04, Vol.15 (4), p.254-259
Main Authors: TOZZI, V, BALESTRA, P, SAMPAOLESI, A, NOTO, P, IPPOLITO, G, WU, A. W, MURRI, R, GALGANI, S, BELLAGAMBA, R, NARCISO, P, ANTINORI, A, GIULIANELLI, M, TOSI, G, FANTONI, M
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The objective of the study was to determine the association of neurocognitive impairment with health-related quality of life (HRQoL) in patients receiving highly active antiretroviral therapy (HAART). Seventy subjects were cross-sectionally analysed with a standardized neuropsychological test battery and a questionnaire including an Italian translation of the MOS-HIV Health Survey. The presence of neurocognitive impairment was significantly associated with lower HRQoL scores: pain (P = 0.03), physical functioning (P = 0.01), role functioning (P = 0.01), social functioning (P = 0.029), mental health (P = 0.001), energy (P = 0.036), health distress (P = 0.002), cognitive functioning (P = 0.05), current health perception (P
ISSN:0956-4624
1758-1052
DOI:10.1258/095646204773557794